Fig. 1
From: New paradigm for stage III melanoma: from surgery to adjuvant treatment
![Fig. 1](http://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12967-019-2012-2/MediaObjects/12967_2019_2012_Fig1_HTML.png)
Melanoma-specific survival following completion lymph-node dissection or observation in the per-protocol analysis of the trial by Faries et al. [4]. Reproduced with permission